TB intervention significantly decreased the protein and gene expression levels of SREBP-1C (Figure 6B,J) (p < 0.01), FASN (Figure 6C,K) (p < 0.01), and GPAT1 (Figure 6D,L) (p < 0.01), while increasing the expression of P-ACC/ACC (Figure 6E) (p < 0.01), leading to a reduction in hepatic triglycerides. Here, SREBF1 is linked to tuberculosis.